Smart Implants Market Report 2025

This Smart Implants market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The smart implants market size has grown rapidly in recent years. It will grow from $4.47 billion in 2024 to $5.22 billion in 2025 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be attributed to improved healthcare infrastructure, expansion of pharmaceutical and biotechnology companies, rise in prevalence of orthopedic diseases, rise in prevalence of chronic ailments, growth in the healthcare spendings.

The smart implants market size is expected to see rapid growth in the next few years. It will grow to $9.69 billion in 2029 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to growing demand for minimally invasive procedures, rising incidence of accidents or sports injuries, growing awareness and education about smart implants, increasing awareness of personalized medicine, rising public awareness about the benefits of smart implants. Major trends in the forecast period include technological advancement, adoption of smart surgical methodologies in dentistry, product innovation, blockchain technology, wireless connectivity.

The escalating demand for minimally invasive procedures is anticipated to be a driving force behind the expansion of the smart implant market in the coming years. Minimally invasive procedures, characterized by their ability to minimize disruption to the body's normal structure and function, are gaining prominence due to their associated benefits, including reduced pain and discomfort, minimal scarring, and lower risk of complications. Smart implants are poised to revolutionize the landscape of minimally invasive surgery by offering real-time feedback, enhancing precision and accuracy, enabling remote control and adjustment, and facilitating data integration and analysis. These features contribute to safer, more effective, and patient-centered minimally invasive procedures across a spectrum of medical specialties. For example, Americans spent over $11.8 billion on minimally invasive procedures in 2023, signaling a growing preference for these advanced surgical techniques.

Major players in the smart implant market are concentrating on creating innovative products, such as implants based on piezoelectric technology, to improve implant durability and patient outcomes. These piezoelectric implants generate electricity from the body's movements, powering functions like antibacterial surfaces or phototherapy, which boost healing and prolong implant life without relying on external power sources. For example, in February 2023, researchers at the University of Pennsylvania developed a smart dental implant. This implant incorporates a bacteria-resistant nanoparticle biofilm and an integrated phototherapy light to protect periodontal tissue from inflammation. Powered by piezoelectric technology, it converts natural oral movements into electricity to power the phototherapy light, supporting tissue health without the need for batteries. Additionally, barium titanate nanoparticles provide a persistent negative charge to deter harmful bacteria, improving implant longevity and reducing the need for replacement.

In February 2024, Exactech, a U.S.-based medical technology company focused on orthopedic implants, formed a partnership with Statera Medical. This collaboration seeks to combine Statera's Goldilocks smart implant technology with Exactech's Equinoxe shoulder system, providing surgeons with real-time data to ensure precise implant selection and enhance joint stability, ultimately improving patient outcomes. Statera Medical, based in Canada, specializes in developing smart implants for shoulder joint replacement.

Major companies operating in the smart implants market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic plc, Stryker, Boston Scientific Corporation, Zimmer Biomet, Terumo Corporation, Smith & Nephew plc, Biotronik, Integra LifeSciences, Cochlear Ltd., CONMED Corporation, Globus Medical Inc., Penumbra Inc., Orthofix Medical Inc., Nevro Corp., Exactech Inc., IQ IMPLANTS USA, Senseonics, Canary Medical Inc., Aleva Neurotherapeutics SA, Intelligent Implants, Rejoint srl, DirectSync Surgical, Smart Implant Solutions.

North America was the largest region in the smart implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the smart implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Smart implants are advanced medical devices engineered to monitor, diagnose, and treat medical conditions within the body with heightened precision and efficacy. They find application across various medical disciplines, offering personalized and targeted healthcare solutions aimed at enhancing patient care, optimizing treatment outcomes, and facilitating proactive management of chronic diseases and conditions.

The primary types of smart implants include orthopedic, cardiovascular, dental, cosmetic, and others. Orthopedic implants, for instance, are surgical devices utilized to repair or support broken bones or joints, thereby improving mobility and alleviating pain. These implants are deployed through both open surgery and minimally invasive procedures. Their diverse applications encompass knee and hip arthroplasty, spine fusion, stents, intraocular lenses, and pacing devices. They are utilized across various healthcare facilities including hospitals, ambulatory surgical centers, specialty clinics, and others.

The smart implants market research report is one of a series of new reports that provides smart implants market statistics, including smart implants industry global market size, regional shares, competitors with smart implants market share, detailed smart implants market segments, market trends, and opportunities, and any further data you may need to thrive in the smart implants industry. This smart implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart implants market consist of revenues earned by entities by providing ophthalmic implants, implantable drug delivery systems, and neurostimulators. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart implant market also includes sales of implantable sensors, implantable cardiovascular devices, and biosensors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.